Physician profile
Leah E Plumblee
NPI 1780118349
$5,383.61
in general payments reported to CMS, 2019-2025
8 companies · $4,678 in 2025
The $4,678 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2022: $41.63 · 2023: $42.11 · 2024: $425 · 2025: $4,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $1,728 · Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $1,728.23 |
| Food and Beverage | $916.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,451.53 | 2022-2025 | |
| Davol INC. | $1,210.29 | 2025 | |
| Atricure, INC. | $221.64 | 2024 | |
| W. L. Gore & Associates, INC. | $203.27 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Kci USA, INC. | $197.19 | 2019 | |
| Integra Lifesciences Corporation | $42.11 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Abbvie INC. | $30.84 | 2025 | |
| Dilon Technologies, INC. | $26.74 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Plumblee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.